Highlighting the emotional impact of vitiligo on patients, Latanya Benjamin, MD, FAAD, FAAP, presents the case of a 35-year-old female patient with growing depigmentation in highly visible areas.
Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Researchers Report Case of Patient With Mogamulizumab-Induced Vitiligo
ReV Up Your Vitiligo Treatment Strategies
Exploring Genetic Factors in Vitiligo and AA
Discovering Dermatology Times: August 2024 Personalized Vitiligo Care Supplement